Aspen Pharmacare Holdings Limited (JSE: APN)
South Africa
· Delayed Price · Currency is ZAR · Price in ZAc 16,773
-748 (-4.27%)
Feb 5, 2025, 5:11 PM SAST
Aspen Pharmacare Holdings Cash Flow Statement
Financials in millions ZAR. Fiscal year is July - June.
Millions ZAR. Fiscal year is Jul - Jun.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Net Income | 4,404 | 5,228 | 6,488 | 4,806 | 4,664 | Upgrade
|
| Depreciation & Amortization | 1,628 | 1,455 | 1,373 | 1,265 | 1,213 | Upgrade
|
| Other Amortization | 345 | 333 | 340 | 372 | 359 | Upgrade
|
| Loss (Gain) From Sale of Assets | 34 | 1 | -1,212 | -165 | -223 | Upgrade
|
| Asset Writedown & Restructuring Costs | 2,592 | 1,986 | 1,573 | 1,115 | 2,383 | Upgrade
|
| Stock-Based Compensation | 117 | 135 | 58 | 67 | 49 | Upgrade
|
| Other Operating Activities | -2,653 | -260 | -594 | -1,299 | -408 | Upgrade
|
| Change in Accounts Receivable | -104 | 327 | -1,355 | 348 | 1,618 | Upgrade
|
| Change in Inventory | 200 | -2,701 | -2,168 | -280 | -727 | Upgrade
|
| Change in Accounts Payable | -338 | -984 | 871 | 580 | -699 | Upgrade
|
| Operating Cash Flow | 6,225 | 5,520 | 5,374 | 6,825 | 8,260 | Upgrade
|
| Operating Cash Flow Growth | 12.77% | 2.72% | -21.26% | -17.37% | 37.62% | Upgrade
|
| Capital Expenditures | -3,117 | -2,230 | -1,963 | -2,045 | -2,039 | Upgrade
|
| Sale of Property, Plant & Equipment | 13 | 5 | 1,830 | 38 | 38 | Upgrade
|
| Cash Acquisitions | -4,350 | -626 | -2,188 | -632 | -338 | Upgrade
|
| Divestitures | 936 | 279 | 434 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -2,416 | -947 | -409 | -1,011 | -407 | Upgrade
|
| Investment in Securities | 52 | 38 | - | - | - | Upgrade
|
| Other Investing Activities | -586 | 60 | 135 | 13,413 | 4,370 | Upgrade
|
| Investing Cash Flow | -9,468 | -3,421 | -2,161 | 9,763 | 1,624 | Upgrade
|
| Long-Term Debt Issued | 13,988 | 7,939 | 14,208 | 14,668 | 14,217 | Upgrade
|
| Long-Term Debt Repaid | -8,784 | -6,768 | -15,831 | -30,266 | -25,641 | Upgrade
|
| Net Debt Issued (Repaid) | 5,204 | 1,171 | -1,623 | -15,598 | -11,424 | Upgrade
|
| Repurchase of Common Stock | -56 | -136 | -1,857 | -50 | -41 | Upgrade
|
| Common Dividends Paid | -1,525 | -1,455 | -1,196 | - | - | Upgrade
|
| Financing Cash Flow | 3,623 | -420 | -4,676 | -15,648 | -11,465 | Upgrade
|
| Foreign Exchange Rate Adjustments | -653 | 843 | 479 | -602 | 1,050 | Upgrade
|
| Net Cash Flow | -273 | 2,522 | -984 | 338 | -531 | Upgrade
|
| Free Cash Flow | 3,108 | 3,290 | 3,411 | 4,780 | 6,221 | Upgrade
|
| Free Cash Flow Growth | -5.53% | -3.55% | -28.64% | -23.16% | 74.75% | Upgrade
|
| Free Cash Flow Margin | 6.95% | 8.08% | 8.84% | 12.66% | 18.48% | Upgrade
|
| Free Cash Flow Per Share | 7.00 | 7.41 | 7.53 | 10.47 | 13.63 | Upgrade
|
| Cash Interest Paid | 2,227 | 1,324 | 765 | 1,205 | 1,652 | Upgrade
|
| Cash Income Tax Paid | 2,149 | 1,614 | 1,691 | 1,630 | 1,411 | Upgrade
|
| Levered Free Cash Flow | 354.13 | 1,776 | -261.63 | 8,820 | 624.88 | Upgrade
|
| Unlevered Free Cash Flow | 1,779 | 2,628 | 256.5 | 9,603 | 1,686 | Upgrade
|
| Change in Net Working Capital | 336 | 1,699 | 4,609 | -5,888 | 2,518 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.